awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53737270-309EA452-2087-47D0-94D3-EC0D82FB229C
Q53737270-309EA452-2087-47D0-94D3-EC0D82FB229C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53737270-309EA452-2087-47D0-94D3-EC0D82FB229C
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.
P2860
Q53737270-309EA452-2087-47D0-94D3-EC0D82FB229C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53737270-309EA452-2087-47D0-94D3-EC0D82FB229C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
788f29350194d53b61dfa73175e96d1067ac773a
P2860
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?